Cas:2586-96-1 Liensinine manufacturer & supplier

Chemical Name:Liensinine

CAS.NO:2586-96-1

Synonyms:4-{[(1R)-6,7-Dimethoxy-2-methyl-1,2,3,4-tetrahydro-1-isoquinolinyl]methyl}-2-{[(1R)-1-(4-hydroxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydro-7-isoquinolinyl]oxy}phenol;4-{[(1R)-6,7-Dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-2-{[(1R)-1-(4-hydroxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl]oxy}phenol;Hiensinine;Phenol, 4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]-2-[[(1R)-1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinyl]oxy]-

Molecular Formula:C₃₇H₄₂N₂O₆

Molecular Weight:610.739

HS Code:

Physical and Chemical Properties:

Melting point:95-99ºC

Boiling point:722.0±60.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.618

PSA:83.86000

Exact Mass:610.304260

LogP:4.84

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-{[(1R)-6,7-Dimethoxy-2-methyl-1,2,3,4-tetrahydro-1-isoquinolinyl]methyl}-2-{[(1R)-1-(4-hydroxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydro-7-isoquinolinyl]oxy}phenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Phenol, 4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]-2-[[(1R)-1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinyl]oxy]- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-{[(1R)-6,7-Dimethoxy-2-methyl-1,2,3,4-tetrahydro-1-isoquinolinyl]methyl}-2-{[(1R)-1-(4-hydroxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydro-7-isoquinolinyl]oxy}phenol Use and application,4-{[(1R)-6,7-Dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-2-{[(1R)-1-(4-hydroxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl]oxy}phenol technical grade,usp/ep/jp grade.

Related News: However, to leverage these benefits, it is vital that biocatalytic processes be evaluated as early in the drug development life cycle as possible. Fortunately, the growing availability of diverse kits of enzyme classes can facilitate this process, allowing researchers to screen enzymes/biocatalysts in much the same way as traditional screening of metal catalysts is performed. (2R,3R,3aS,6aR)-2-((2S,3R,3aS,6aR)-2-Benzyloxy-5,5-dimethyl-hexahydro-1,4,6-trioxa-cyclopropa[e]inden-3-yloxy)-5,5-dimethyl-hexahydro-1,4,6-trioxa-cyclopropa[e]inden-3-ol manufacturers For its part, the FDA’s representative at the meeting, Doran Fink, M.D., said the drug regulator is “working as rapidly as possible to conduct a thorough and comprehensive” review of all the COVID-19 vaccines that have applied for full approval. Pfizer and Moderna recently submitted their applications for a full nod. (Z)-3-Biphenyl-4-yl-3-hydroxy-dithioacrylic acid suppliers MG is a “serious, lifelong disease with life-threatening manifestations, and most patients do not achieve treatment goals with conventional therapy,” the report said. 4,4,6,6-tetrahydroxy-1-(5-hydroxy-3-(1-oxidaneyl)-13,24,34,43,54,63-hexaoxin-2-yl)-24,44,64-heptaoxidan-2-one vendor & factory.